News Release Details
Verrica Pharmaceuticals Announces Participation in the Jefferies 2019 Healthcare Conference
A live audio webcast of the event will be available in the Investors/Events & Presentations section of the Verrica website at http://www.verrica.com/. A webcast replay will also be available on this website shortly after conclusion of the event for 30 days.
Verrica is a medical dermatology company committed to the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases. The company’s late-stage product candidate, VP-102, is a potential first-in-class topical therapy for the treatment of molluscum contagiosum, a highly contagious viral skin infection affecting approximately six million people, primarily children, in
Chief Financial Officer
484.453.3300 ext. 103
Source: Verrica Pharmaceuticals Inc.